-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Edward Mansley, PhD

Articles by Edward Mansley, PhD

Do Drug Formulary Policies Reflect Evidence of Value?

ByPeter J. Neumann, ScD,Pei-Jung Lin, MS,Dan Greenberg, PhD,Marc L. Berger, MD,Steven M. Teutsch, MD,Edward Mansley, PhD,Milton C. Weinstein, PhD,Allison B. Rosen, MD, ScD

January 1st 2006

Latest Updated Articles

Do Drug Formulary Policies Reflect Evidence of Value?
January 1st 2006

Trending on AJMC

Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges

Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote

Surrogate End Points, Drug Costs Complicate Oncology Formularies

Perceptions About CGMs Among Primary Care Physicians and Endocrinologists

FDA Approves Belzutifan-Lenvatinib Combo for Advanced Kidney Cancer